January 30, 2012 -- Transgene announced two new China-related initiatives: with three European institutions, Transgene formed a scientific cooperation program that includes Fudan University Shanghai Cancer Center; it also established a Shanghai subsidiary with a staff of five to perform academic and early-stage projects. Transgene, a French biopharma, positioned the moves as a way of taking advantage of China’s impressive research activity as well as the country’s market for pharmaceuticals. More details....
Stock Symbol: (Euronext: TNG)
